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Abstract
Purpose/Background: Exposure therapy is one of the most potent techniques available to treat
social anxiety. However, studies suggest that exposure therapy only produces full remission in
20-50% of patients. Furthermore, laboratory conditioning and extinction studies suggest that fear
responses toward individuals who differ from one’s own ethnicity/race may be more resistant to
extinction. Because activation of the medial prefrontal cortex has been associated with facilitating
fear reduction during exposure therapy, we expect that targeting activation of this region with a
stimulation technique called transcranial direct current stimulation (tDCS) may improve outcomes
from exposure therapy for social anxiety. The present study will therefore test the hypotheses that
(1) fear responding at baseline will be greater toward an audience that does not match (vs matches)
the participant’s own ethnicity, (2) pairing exposure therapy with active (vs sham) tDCS will facili-
tate alleviation of social anxiety symptoms, and (3) pairing exposure therapy with active (vs sham)
tDCS facilitates extinction of fear response toward individuals who differ from the participant’s
own ethnicity.
Materials & Methods: We are recruiting Latino and non-Latino/Caucasian undergraduates with
a fear of public speaking, the most commonly feared situation among individuals with social anx-
iety. Participants (N = 128) will receive either active/anodal (n = 64) or sham (n = 64) tDCS
stimulation targeting the mPFC during an exposure therapy session delivered through virtual real-
ity (VR). During exposure therapy, participants will complete six, 3-minute public speaking trials,
alternating in a randomized order between audiences that are 75% matched to the participant’s
ethnicity and 75% unmatched to the participant’s ethnicity. At one-month follow up, participants
will complete two behavioral avoidance tests (BATs) parallel to therapy procedures, with one
ethnic-matched trial and one ethnic-unmatched trial. Fear response during each BAT will be as-
sessed behaviorally (duration of speech), physiologically (heart rate variability and electrodermal
response), and subjectively (peak fear rating, on a 0 to 100 scale). At baseline and one-month
follow-up, participants will also complete a battery of social anxiety questionnaires.
Results: We will present methods and preliminary findings from the study. Results will include
a preliminary examination of whether fear responding is greater toward individuals who differ
from (vs match) the participant’s own ethnicity, whether pairing exposure therapy with active (vs
sham) tDCS facilitates alleviation of social anxiety symptoms overall, and whether pairing expo-
sure therapy with active (vs sham) tDCS facilitates alleviation of social anxiety responding toward
individuals who differ from (vs match) the participant’s own ethnicity.
Discussion/Conclusion: Findings point to key strategies to improve outcomes from exposure ther-
apy for social anxiety, and could also have implications for improving response to exposure-based
therapies for other anxiety disorders. Furthermore, if tDCS facilitates reductions in fear response
toward ethnic/racial out-groups, minority/Latino individuals may experience better generalization
of treatment effects for daily-life scenarios (in which they are surrounded by outgroup members),
and ethnic/racial majority individuals will be better able to contribute to an inclusive social envi-
ronment.
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ABSTRACT 
Purpose/Background: Exposure therapy is one of the most potent techniques available to 
treat social anxiety. However, studies suggest that exposure therapy only produces full remission 
in 20-50% of patients. Furthermore, laboratory conditioning and extinction studies suggest that 
fear responses toward individuals who differ from one's own ethnicity/race may be more resistant 
to extinction. Because activation of the medial prefrontal cortex has been associated with 
facilitating fear reduction during exposure therapy, we expect that targeting activation of this 
region with a stimulation technique called transcranial direct current stimulation (tDCS) may 
improve outcomes from exposure therapy for social anxiety. The present study will therefore test 
the hypotheses that (1) fear responding at baseline will be greater toward an audience that does not 
match (vs matches) the participant's own ethnicity, (2) pairing exposure therapy with active (vs 
sham) tDCS will facilitate alleviation of social anxiety symptoms, and (3) pairing exposure therapy 
with active (vs sham) tDCS facilitates extinction of fear response toward individuals who differ 
from the participant's own ethnicity. 
Materials & Methods:  We are recruiting Latino and non-Latino/Caucasian undergraduates 
with a fear of public speaking, the most commonly feared situation among individuals with social 
anxiety. Participants (N = 128) will receive either active/anodal (n = 64) or sham (n = 64) tDCS 
stimulation targeting the mPFC during an exposure therapy session delivered through virtual 
reality (VR). During exposure therapy, participants will complete six, 3-minute public speaking 
trials, alternating in a randomized order between audiences that are 75% matched to the 
participant's ethnicity and 75% unmatched to the participant's ethnicity. At one-month follow up, 
participants will complete two behavioral avoidance tests (BATs) parallel to therapy procedures, 
with one ethnic-matched trial and one ethnic-unmatched trial. Fear response during each BAT will 
be assessed behaviorally (duration of speech), physiologically (heart rate variability and 
electrodermal response), and subjectively (peak fear rating, on a 0 to 100 scale). At baseline and 
one-month follow-up, participants will also complete a battery of social anxiety questionnaires. 
Results:   We will present methods and preliminary findings from the study. Results will 
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include a preliminary examination of whether fear responding is greater toward individuals who 
differ from (vs match) the participant's own ethnicity, whether pairing exposure therapy with active 
(vs sham) tDCS facilitates alleviation of social anxiety symptoms overall, and whether pairing 
exposure therapy with active (vs sham) tDCS facilitates alleviation of social anxiety responding 
toward individuals who differ from (vs match) the participant's own ethnicity. 
Discussion/Conclusion:  Findings point to key strategies to improve outcomes from 
exposure therapy for social anxiety, and could also have implications for improving response to 
exposure-based therapies for other anxiety disorders. Furthermore, if tDCS facilitates reductions 
in fear response toward ethnic/racial out-groups, minority/Latino individuals may experience 
better generalization of treatment effects for daily-life scenarios (in which they are surrounded by 
outgroup members), and ethnic/racial majority individuals will be better able to contribute to an 
inclusive social environment. 
